ask="100.00"
ask_size="200"
average_daily_volume="534026"
bid="55.00"
bid_size="10000"
book_value="11.38"
change="-1.53"
change_from_200_day_moving_average="1.50"
change_from_50_day_moving_average="-0.67"
change_from_52_week_high="-15.39"
change_From_52_week_low="24.86"
change_in_percent="-2.10%"
close="71.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="72.84"
high_52_weeks="86.77"
last_trade_date="2/8/2017"
last_trade_price="71.38"
last_trade_size="56685"
last_trade_time="4:00pm"
low="71.03"
low_52_weeks="46.52"
market_capitalization="2.92B"
moving_average_200_day="69.88"
moving_average_50_day="72.05"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="72.37"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+2.15%"
percent_change_from_50_day_moving_average="-0.93%"
percent_change_from_52_week_high="-17.74%"
percent_change_from_52_week_low="+53.44%"
previous_close="72.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.41"
price_per_sales="23273.67"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="425702"
weeks_range_52="46.52 - 86.77"
